ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Qilian International Holding Group Ltd

Qilian International Holding Group Ltd (QLI)

0.7486
-0.0404
(-5.12%)
Closed April 27 4:00PM
0.6842
-0.0644
(-8.60%)
After Hours: 7:53PM

Get an advanced news scanner tailored to your needs by ADVFN

Enhance your trading experience

QLI News

Official News Only

QLI Discussion

View Posts
TimeFades TimeFades 2 weeks ago
Another pump n dump
πŸ‘οΈ0
stock1ace1 stock1ace1 1 month ago
Front loaded p&d
πŸ‘οΈ0
Awl416 Awl416 1 month ago
Woof
πŸ‘οΈ0
wesley_ wesley_ 3 years ago
$5.20 nice
πŸ‘οΈ0
Surfacetite Surfacetite 3 years ago
Saw this $19 premkt and figured I wait.

Got in at 12.22.

That low float got me.
πŸ‘οΈ0
realtmg realtmg 3 years ago
Looking good here
πŸ‘οΈ0
$treet $inatra $treet $inatra 3 years ago
Quite the ride on this low float! Priced @ $5 - Opened @ $8 - High of $22 all in 1 day
πŸ‘οΈ0
$treet $inatra $treet $inatra 3 years ago
$QLI ipo today https://www.streetinsider.com/Corporate+News/Qilian+International+Holding+Group+Ltd+%28QLI%29+Prices+5M+Share+IPO+at+%245Sh/17810169.html


Qilian International Holding Group Ltd (QLI) Prices 5M Share IPO at $5/Sh

Qilian International Holding Group Limited (NASDAQ: QLI), a China-based pharmaceutical and chemical products manufacturer, today announced the pricing of its initial public offering ("Offering") of 5,000,000 ordinary shares at a public offering price of US$5.00 per share. The ordinary shares have been approved for listing on the Nasdaq Global Market and are expected to commence trading on January 12, 2021 under the ticker symbol β€œQLI”.

The Company expects to receive aggregate gross proceeds of US$25 million from this Offering, before deducting underwriting discounts and other related expenses. In addition, the Company has granted the underwriters a 45-day option to purchase up to an additional 750,000 ordinary shares at the public offering price, less underwriting discounts. The Offering is expected to close on or about January 14, 2021, subject to the satisfaction of customary closing conditions.

Proceeds from the Offering will be used for fixed asset investment in Oxytetracycline API production facilities, construction of an organic-waste treatment facility, fixed asset investment in Heparin Sodium Preparation facilities, and marketing expenses for Gan Di Xin ®.

The Offering is being conducted on a firm commitment basis. Univest Securities, LLC is acting as the representative of the underwriters and lead book-running manager for the Offering. Loop Capital Markets and Alexander Capital L.P. are acting as co-managers for the Offering. Hunter Taubman Fischer & Li LLC acted as counsel to the Company, and Ortoli Rosenstadt LLP acted as counsel to Univest Securities, LLC in connection with the Offering.
πŸ‘οΈ0

Your Recent History

Delayed Upgrade Clock